Tyra Biosciences Inc
NASDAQ:TYRA

Watchlist Manager
Tyra Biosciences Inc Logo
Tyra Biosciences Inc
NASDAQ:TYRA
Watchlist
Price: 26.79 USD 1.9% Market Closed
Market Cap: 1.4B USD

Net Margin
Tyra Biosciences Inc

0%
Current
0%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-111.7m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Tyra Biosciences Inc
Glance View

Market Cap
1.4B USD
Industry
Biotechnology

Tyra Biosciences, Inc. develops therapies for oncology and cancer diseases. The company is headquartered in Carlsbad, California and currently employs 25 full-time employees. The company went IPO on 2021-09-15. The firm is focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. The firm uses its proprietary SNAP platform, which enables refinement of structural design through iterative molecular SNAPshots. The firm is focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR), which are altered in approximately 7% of all cancers. Its lead product candidate, TYRA-300, is designed to selectively inhibit FGFR3, with an initial focus on patients with bladder cancer. In addition, it has pipeline development programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during Transfection kinase (RET), and FGFR4-related cancers.

TYRA Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-111.7m
/
Revenue
0
What is the Net Margin of Tyra Biosciences Inc?

Based on Tyra Biosciences Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top